In recent years, the development of hyaluronic acid or hyaluronan (HA) based scaffolds,
medical devices, bioconjugate systems have expanded into a broad range of research and …

Nanocarriers (NCs) are a type of drug delivery system commonly used to regulate the
pharmacokinetic and pharmacodynamic properties of drugs. Although a wide variety of NCs …

Hyaluronic acid (HA) is a glycosaminoglycan that is found in extracellular tissue in many
parts of the body. It is a material of increasing importance to biomaterials science and is …

Background and aims In one-third of patients with acute coronary syndrome (ACS),
thrombosis occurs despite an intact fibrous cap (IFC)(IFC–ACS,'plaque erosion'). Recent …

Polysaccharides can be elite carriers for therapeutic molecules due to their versatility and
low probability to trigger toxicity and immunogenic responses. Local and systemic therapies …

Patients with wet age-related macular degeneration (AMD) require intravitreal injections of
bevacizumab (Bev) or other drugs, often on a monthly basis, which is a burden on the …

Accelerating interest by the pharmaceutical industry in the identification and development of
less invasive routes of nanomedicine administration, coupled with defined efforts to improve …

The toll-like receptor 7 and 8 (TLR7/8) agonist Resiquimod (R848) has been recognized as
a promising immunostimulator for the treatment of cutaneous cancers in multiple clinical …

Recent developments in the fabrication of core-shell polymer nanocapsules, as well as their
current and future applications, are reported here. Special attention is paid to the newly …

This review shows the steps towards material selection focalized on the design and
development of medical devices based on hyaluronan (HA). The selection is based on …